BELLEROPHON THERAPEUTICS INC (BLPH) Stock Balance Sheet
NASDAQ:BLPH - Nasdaq - US0787713009 - Common Stock - Currency: USD
| MRQ (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 10.57M | 6.92M | 24.74M | 47.56M | 9.87M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 670.00K | 639.00K | 723.00K | 520.00K | 510.00K | |||
| Total Current Assets | 11.24M | 7.56M | 25.46M | 48.08M | 10.38M | |||
| Non-Current Assets | ||||||||
| PPE Net | 0.00 | 186.00K | 930.00K | 1.67M | 2.43M | |||
| Other Non-Current Assets | 0.00 | 186.00K | 486.00K | 490.00K | 300.00K | |||
| Total Non-Current Assets | 0.00 | 372.00K | 1.42M | 2.16M | 2.73M | |||
| TOTAL ASSETS | 11.24M | 7.93M | 26.88M | 50.24M | 13.11M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 3.73M | 4.17M | 3.86M | 6.71M | 4.48M | |||
| Accounts Payable | 1.89M | 1.23M | 1.19M | 3.73M | 3.11M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 5.62M | 5.40M | 5.05M | 10.43M | 7.58M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | 0.00 | 204.00K | 1.56M | 1.93M | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 204.00K | 1.56M | 1.94M | |||
| TOTAL LIABILITIES | 5.62M | 5.40M | 5.26M | 11.99M | 9.52M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -254.39M | -252.08M | -232.25M | -214.49M | -189.76M | |||
| Additional Paid In Capital | 259.89M | 254.52M | 253.77M | 252.65M | 193.31M | |||
| Common Shares | 122.00K | 96.00K | 95.00K | 100.00K | 50.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 12.23M | 9.65M | 9.55M | 9.49M | 4.58M | |||
| Tangible Book Value per Share | 0.46 | 0.26 | 2.26 | 4.03 | 0.78 | |||
| Total Shareholders' Equity | 5.62M | 2.53M | 21.62M | 38.25M | 3.59M | |||
| TOTAL LIABILITIES AND EQUITY | 11.24M | 7.93M | 26.88M | 50.24M | 13.11M | |||
| Statistics | ||||||||
| Current Ratio | 2.00 | 1.40 | 5.04 | 4.61 | 1.37 | |||
| Return On Assets (ROA) | -110.28% | -249.92% | -66.07% | -49.22% | -101.22% | |||
| Return On Equity (ROE) | -220.54% | -782.60% | -82.13% | -64.65% | -369.64% | |||
All data in USD , ROIC based on taxRate of 0.21